Search

Your search keyword '"Artan, Reha"' showing total 362 results

Search Constraints

Start Over You searched for: Author "Artan, Reha" Remove constraint Author: "Artan, Reha"
362 results on '"Artan, Reha"'

Search Results

2. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

3. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

5. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease

10. Evaluation of malnutrition development risk in hospitalized children

12. Artificial Neural Network (ANN) Validation Research: Free Vibration Analysis of Functionally Graded Beam via Higher-Order Shear Deformation Theory and Artificial Neural Network Method.

14. Novel immunodeficiency caused by homozygous mutation in SLC19A1 encoding the reduced folate carrier

15. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

16. Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey

19. Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With İnflammatory Bowel Disease: A Multicenter Study

20. Relationships between decreases in serum bile acids, pruritus, and sleep disturbance scores with up to 72 weeks of odevixibat treatment in patients with progressive familial intrahepatic cholestasis

21. Changes in hepatic parameters, growth, sleep, and biochemical markers with odevixibat treatment across patients with various types of progressive familial intrahepatic cholestasis

22. Analysis of quality of life, hepatic biochemical markers, and sleep in patients with progressive familial intrahepatic cholestasis who had a pruritus response with odevixibat treatment

23. Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis

24. EP1228: DISEASE BURDEN AND NATURAL HISTORY OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: BASELINE CLINICAL CHARACTERISTICS AMONG ODEVIXIBAT-TREATED PATIENTS IN THE PHASE 3 PEDFIC STUDIES

25. EP1229: RELATIONSHIPS BETWEEN DECREASES IN SERUM BILE ACIDS, PRURITUS, AND SLEEP DISTURBANCE SCORES WITH UP TO 72 WEEKS OF ODEVIXIBAT TREATMENT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

26. EP1232: ODEVIXIBAT EFFECTS ON CHOLESTASIS-RELATED PARAMETERS: ANALYSIS OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

27. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

29. O12 Hepatic parameters, growth, and sleep with responders and nonresponders to odevixibat treatment: pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis

30. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region

32. HEPATIC PARAMETERS, GROWTH, AND SLEEP WITH RESPONDERS AND NONRESPONDERS TO ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS

33. Odevixibat effects on cholestasis-related parameters: Analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis

34. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region.

36. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease

50. Mide Çıkım Tıkanıklığı Sendromu.

Catalog

Books, media, physical & digital resources